Get the Stockscreener App
0.5125
1.23%
0.0094
Veru Inc stock is traded at $0.5125, with a volume of 681.13K.
It is up +1.23% in the last 24 hours and down -3.08% over the past month.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
See More
Previous Close:
$0.5031
Open:
$0.5
24h Volume:
681.13K
Relative Volume:
0.42
Market Cap:
$73.48M
Revenue:
$15.93M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.6833
EPS:
-0.75
Net Cash Flow:
$-59.50M
1W Performance:
-2.45%
1M Performance:
-3.08%
6M Performance:
-12.73%
1Y Performance:
-65.35%
1-Day Range:
$0.4965
$0.5157
1-Week Range:
$0.495
$0.5434
52-Week Range:
$0.45
$1.50
Veru Inc Stock (VERU) Company Profile
Name
Veru Inc
Sector
Industry
Phone
(312) 595-9123
Address
2916 N. MIAMI AVENUE, MIAMI, FL
Compare VERU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
0.5093 | 73.48M | 15.93M | -64.59M | -59.50M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.28 | 111.66B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.55 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
557.61 | 38.04B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
284.55 | 36.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
225.19 | 25.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Initiated | B. Riley Securities | Buy |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Jun-07-23 | Upgrade | Jefferies | Underperform → Hold |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Feb-09-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jul-03-18 | Initiated | Maxim Group | Buy |
View All
Veru Inc Stock (VERU) Latest News
Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN
Barclays PLC Acquires 21,738 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru Inc. (NASDAQ:VERU) Stake Raised by Wells Fargo & Company MN - Defense World
Veru (NASDAQ:VERU) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Veru Inc. (NASDAQ:VERU) Q2 2025 Earnings Call Transcript - Insider Monkey
Veru Inc. Reports Progress in Clinical Trials and Financials - TipRanks
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... - Yahoo Finance
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial Challenges - GuruFocus
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewswire
Veru Q2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Veru Inc. beats Q2 2025 EPS forecast, stock rises - Investing.com Nigeria
Veru Inc. (VERU) Advances Obesity Program with Promising Trial Results - GuruFocus
VERU INC. SEC 10-Q Report - TradingView
Veru Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Veru Participates in a Virtual Investor KOL Connect Segment | VERU Stock News - GuruFocus
JTC Team Hosts Virtual Investor “KOL Connect” Segment to Discuss Veru Inc.’s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Sacramento Bee
JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Mid Florida Newspapers
Veru Participates in a Virtual Investor KOL Connect Segment - GlobeNewswire
2 Beaten-Down Stocks That Are Great Buys on the Dip - The Globe and Mail
Veru Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
Veru Inc (VERU) Reports Q2 Fiscal 2025 EPS of -$0.05, Beating Estimates of -$0.06; Revenue Focus Remains on Clinical Progress - GuruFocus
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress | VERU Stock News - GuruFocus
Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For - GuruFocus
Envestnet Asset Management Inc. Buys 75,997 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru (VERU) Projected to Post Earnings on Thursday - MarketBeat
Financial Snapshot: Analyzing Veru Inc (VERU)’s Key Ratio Metrics - DWinneX
Veru Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Has $166,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
Adage Capital Partners GP L.L.C. Sells 5,561,111 Shares of Veru Inc. (NASDAQ:VERU) - MarketBeat
NewEdge Advisors LLC Raises Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
Check out these key findings about Veru Inc (VERU) - Sete News
Veru Inc (VERU)’s stock price range in the last year - uspostnews.com
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8 - The Manila Times
Veru Inc. to Host Conference Call for Fiscal Q2 2025 Financial Results and Business Update on May 8, 2025 - Nasdaq
B. Riley Securities gives a Buy recommendation for Veru Inc (VERU) - knoxdaily.com
Veru Inc (VERU) Stock: A Comprehensive 52-Week Review - investchronicle.com
Geode Capital Management LLC Increases Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
ImmunityBio Inc’s Market Journey: Closing Weak at 2.61, Down -2.97 - DWinneX
Trading Day Review: Capri Holdings Ltd (CPRI) Gains Momentum, Closing at 14.87 - DWinneX
Market Momentum: Coherus Biosciences Inc (CHRS) Registers a 1.98 Increase, Closing at 1.03 - DWinneX
Stock Performance Spotlight: Veru Inc (VERU) Ends the Day at 0.54, Down by -2.02 - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Veru Inc. (VERU) Investigation - ACCESS Newswire
SOBO Shares Experience Surge in Value - knoxdaily.com
Was Veru Inc (VERU)’s session last reading good? - uspostnews.com
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit | VERU Stock News - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit - GlobeNewswire
Veru Inc Stock (VERU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):